Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids

Gut

Volumn 43, Issue 2, 1998, Pages 223-228

  Granberg, D ^a   Wilander, E ^b   Stridsberg, M ^b   Granerus, G ^b   Skogseid, B ^a   Oberg K ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromogranin; Gastric carcinoids; Histamine; Interferon; Octreotide

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; CALCITONIN; CHORIONIC GONADOTROPIN; CHROMOGRANIN A; CHROMOGRANIN B; FLUOROURACIL; FOTEMUSTINE; GAMMA INTERFERON; GASTRIN; HORMONE; OCTREOTIDE; PANCREAS POLYPEPTIDE; STREPTOZOCIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; GASTRIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION; SYNDROME DELINEATION;

EID: 0031850702     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.2.223     Document Type: Article

References (37)

1. Williams HD, Sandler M. The classification of carcinoid tumors. Lancet 1963;1:238-9.
2. Granerus G, Lindell SE, Waldenström J, et al. Histamine metabolism in carcinoidosis. Lancet 1966:1267-8.
3. Bordi C, Baggi MT, Davoli C, et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 1991;67:663-72.
4. Grigioni WF, Caletti GC, Gabrielli M, et al. Gastric carcinoids of FCL cells. Pathological and clinical analysis of eight cases. Acta Pathologica Japonica 1985;35:361-75.
5. Lehy T, Cadiot G, Mignon M, et al. Influence of multiple endocrine neoplasia type I on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992; 331:275-9.
6. Müller J, Kirchner T, Müller-Hermelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol 1987;11:909-17.
7. Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
8. Solcia E, Capella C, Sessa F, et al. Gastric carcinoids and related endocrine growths. Digestion 1986;35(suppl 1):3-22.
9. Solcia F, Capella C, Fiocca R, et al. The gastroenteropancreatic endocrine system and related tumors. Gastroenterol Clin North Am 1989;18:671-93.
10. Solcia F, Gapella C, Buffa R, et al. Endocrine cells of the gastrointestinal tract and related tumors. Pathobiology Annual 1979;9:163-204.
11. Wilander E, El-Salhy M, Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology 1984;8: 183-93.
12. Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88:638-48.
13. Thomas RM, Baybick JH, Elsayed AM, et al. Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994;73:2053-8.
14. Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988;39:61-79.
15. Wilander F, Nordgren H, Öberg K. Nonantral gastric carcinoid tumors associated with hypergastrinemia. Acta Med Scand 1986;219:393-7.
16. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988;41:185-200.
17. Carney JA, Go VLW, Fairbanks VF, et al. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 1983;99:761-6.
18. Solcia E, Capella C, Fiocca R, et al. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. Am J Surg Pathol 1990;14:503-13.
19. Stridsberg M, Hellman C, Wilander F, et al. Fragments of chromogranin A are present in the urine of patients with carcinoid tumors: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 1993;139:329-37.
20. Stridsberg M, Öberg K, Li Q, et al. Measurement of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995;144:49-59.
21. Lundqvist G, Wide L. Serum gastrin determination with a radioimmunosorbent technique. Clin Chim Acta 1977;79: 357-62.
22. Hällgren R, Lundqvist G, Chance RE. Serum levels of human pancreatic polypeptide in renal disease. Scand J Gastroenterol 1977;12:923-7.
23. Almqvist S, Telenius-Berg M, Wästhed B. Serum calcitonin in medullary thyroid carcinoma. Acta Medica Scandinavica 1974;196:177-80.
24. Oberg K, Wide L. HCG and HCG-subunits as tumour markers in patients with endocrine pancreatic rumours and carcinoids. Acta Endocrinologica (Copenhagen) 1981;98: 256-60.
25. Bordi C, Paolo Pilato F, Bertelé A, et al. Impression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia. Hum Pathol 1988;19:580-5.
26. Solda H, Fiocca R, Villani L, et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1996;26(suppl 180):146-59.
27. Ferraro G, Annibale B, Marignani M, et al. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab 1996;81:677-83.
28. Kahn CR, Rosen SW, Weintraub BD, et al. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy. N Engl J Med 1977;297:565-9.
29. Tiensuu Janson E, Holmberg L, Stridsberg M, et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997;8:685-90.
30. Harvey RF. Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet 1988; i:821.
31. Hirschowitz BI, Griffith J, Pellegrin D, et al. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102:1409-18.
32. McAleese P, Moorehead J. Multiple gastric carcinoid tumours in a patient with pernicious anemia: endoscopic removal or gastric resection? Eur J Surg 1994;160:243-6.
33. Thirlby RC. Management of patients with gastric carcinoid tumors. Gastroenterology 1995;108:296-7.
34. Eriksson B, Skogseid B, Lundqvist G, et al. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990;65:1883-90.
35. Öberg K, Enksson B. Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncol 1989;28:425-31.
36. Tiensuu Janson KM, Ahlström H, Andersson T, et al. Octreotide and interferon-alpha: a new combination for the treatment of malignant carcinoid tumors. Eur J Cancer 1992;28A:1647-50.
37. Eriksson B, Öberg K, Skogseid B. Neuroendocrine pancreatic tumors: clinical findings in a prospective study of 84 patients. Acta Oncol 1089;28:373-7.